Free Trial

Clene (CLNNW) Competitors

$0.02 0.00 (0.00%)
As of 07/3/2025

CLNNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Clene stock or one of its competitors? The main competitors of Clene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Clene vs. Its Competitors

Clene (NASDAQ:CLNNW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

Company Net Margins Return on Equity Return on Assets
CleneN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Clene's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Clene Neutral
180 Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clene$350KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Clene beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLNNW vs. The Competition

MetricCleneBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.96M$5.55B$9.04B
Dividend YieldN/A3.74%5.22%4.00%
P/E RatioN/A3.4027.6420.24
Price / SalesN/A4,084.30417.15117.30
Price / CashN/A13.1936.8958.10
Price / BookN/A42.828.035.67
Net IncomeN/A-$92.79M$3.18B$249.21M
7 Day PerformanceN/A2.49%2.93%3.28%
1 Month PerformanceN/A2.58%1.72%3.95%
1 Year PerformanceN/A181.40%34.39%20.98%

Clene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLNNW
Clene
N/A$0.02
flat
N/A-29.7%$0.00$350K0.00100
ATNFW
180 Life Sciences
N/A$0.01
-4.8%
N/A-6.9%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.15
flat
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.70
+13.3%
N/A-41.9%$0.00$585.60M0.004
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-0.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/A+200.3%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
-31.5%
N/A-97.5%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.08
+0.1%
N/A-70.6%$0.00N/A0.008Gap Up

Related Companies and Tools


This page (NASDAQ:CLNNW) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners